Grifols, S.A. (GRFS) Social Stream

Grifols, S.A. (GRFS)

Today's Latest Price: $16.86 USD

0.47 (-2.71%)

Updated Oct 29 4:00pm

Add GRFS to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

Featured Post From StockTwits About GRFS

$GRFS As a retired immunologist, I think there is a good chance that the shotgun approach of hyperimmune convalescent plasma immunoglobulin will prove to be superior to the .22 approach of the LLY and REGN monoclonals. Moreover, the cost of the GRFS product will be a small fraction of the monoclonal antibodies, and they can be given as a simple injection versus the IV infusion for the monoclonals. I think this is going to provide a real tailwind for GRFS
mghmd, published October 28, 2020

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5086 seconds.